MedPath

Effectiveness of Cannabidiol Vs. Narcotics for Post Operative Pain Control in Elective Shoulder Arthroscopic Surgery

Early Phase 1
Completed
Conditions
Post-operative Pain
Interventions
Registration Number
NCT05240755
Lead Sponsor
Foundation for Orthopaedic Research and Education
Brief Summary

This study is a prospective, randomized, nonblinded trial to evaluate the effectiveness of Cannabidiol (CBD) oil on post-operative pain control compared to opioid medications.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Age 18 years or older
  • Requiring shoulder arthroscopic surgery for soft tissue pathology
  • Able to complete surveys and follow-up visits
Exclusion Criteria
  • Younger than 18 years of age
  • Shoulder dislocation, fracture, previous surgery, coexisting extremity pathology, pregnancy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Cannabidiol Oil 100 mgCannabidiol OilCBD 100 mg PO liquid suspension QD starting 30 days prior and finishing 30 days post-op
Cannabidiol Oil 200 mgCannabidiol OilCBD 200 mg PO liquid suspension QD starting 30 days prior and finishing 30 days post-op
Primary Outcome Measures
NameTimeMethod
Post-operative pain30 days post-operatively

Numerical Pain Scale (NRS): 0 being no pain, 10 being the worst pain imaginable. Higher scores are worse outcomes.

Secondary Outcome Measures
NameTimeMethod
Sleep Quality30 days preoperatively leading up to surgery then 30 days postoperatively as well. Outcomes will be collected from surgery to 6 weeks postoperatively.

Insomnia Severity Index

Trial Locations

Locations (1)

Florida Orthopaedic Institute

🇺🇸

Tampa, Florida, United States

Florida Orthopaedic Institute
🇺🇸Tampa, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath